glp 1 hairloss Hair loss has increasingly been reported among patients using GLP-1 and GIP agonists for weight loss. These include drugs like semaglutide, tirzepatide, liraglutide and others. Historically, this hair loss has been attributed Weight loss is often the

Both medications are now recognized by major medical organizations as appropriate options for non-diabetic individuals meeting body mass index or weight-related health criteria

References van Lieshout, E

Padgett, L

The ability to counteract side effects while leaving desired effects intact is a holy grail of modern medical research as it would improve therapeutic benefits for a number of drugs

Many adults with CVS have sympathetic nervous system dysregulation.10,25,26 Studies have reported increases in sympathetic tone in patients with CVS, recorded through various tests of autonomic function, such as postural adjustment ratio, heart rate variability, tilt table test, and sudomotor tests.10,2729 The most frequent finding in these reports was an adrenergic anomaly, in addition to coexisting abnormalities of vagal cholinergic function